Lee JY, Jung S, Choi S, Park S-S, Kim JS, Lee J-J, Park SK, Kim HJ, Lee G-W, Park YH, Eom H-S, Kim J-A, Kim MK, Kim Y, Shin H-J, Lee HS, Kwon J, Min C-K. Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study). haematol [Internet]. 2020Sep.10 [cited 2025Dec.5];. Available from: https://haematologica.org/article/view/12208